German laboratory equipment producer Synlab said on Monday that UK private equity firm Cinven had submitted a non-binding offer to fully take over the company at 10 euros per share.
“This expression of interest was not coordinated with the Company and it is currently not foreseeable whether there will be a public acquisition offer on the part of Cinven to all shareholders of Synlab AG”, the German company said.
Synlab’s shares extended their gains and were trading at around 9 euros per share at 1130 GMT, up around 30% from market open.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
This put the company on track for its best day ever and the stock topped Germany’s small-cap index which was down 2.41%.
Bloomberg News had earlier reported that Cinven, which holds a 43% stake, was considering taking Synlab private following its IPO two years ago.
The asset manager was weighing the move as demand for testing vanishes following the COVID-19 pandemic, Bloomberg added, citing people familiar with the matter.
Source: Yahoo Finance
Can’t stop reading? Read more
TA Associates eyes $810m takeover of UK-listed Advanced Medical Solutions
TA Associates eyes $810m takeover of UK-listed Advanced Medical Solutions TA Associates is in...
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Partners Group has closed its latest private...
Ares commits $300m to scale Clearwater’s C-PACE real estate credit platform
Ares commits $300m to scale Clearwater’s C-PACE real estate credit platform Ares has committed up...